Pharmaceutical News

RSS

Linkam and Cambridge IVF work on the development of new protocols for sperm testing

IVF is becoming increasingly important as fertility and birth rates fall in developed countries. Ensuring patients get the right treatment is important both from an emotional and financial perspective...

From Linkam Scientific Instruments 18 May 2015

Lab M demonstrates quality with compliance to ISO 11133:2014

Lab M has been compliant according to ISO 11133:2014 which relates to the microbiology of food, animal feed and water – culture media preparation, production, storage and testing...

18 May 2015

Regular use of aspirin may slow the progression of early emphysema, new research shows

Regular use of aspirin may help slow the progression of early emphysema, according to new research presented at the 2015 American Thoracic Society International Conference.

18 May 2015

Endo Announces Updated XIAFLEX® Label in Patients with Dupuytren’s Contracture

DC is a chronic condition affecting the hand in which abnormal buildup of collagen can cause the fingers to bend and be drawn in toward the palm...

18 May 2015

Study compares effectiveness of treatments for metastatic non-clear cell kidney cancers

A head-to-head comparison of two biologic therapies used to treat a subset of patients with advanced kidney cancers provides much-needed clarity on the preferred treatment for the first line of attack.

15 May 2015

Combination of contraceptive and cholesterol-lowering drugs kills cancer cells in a new way

The combination of a cholesterol-lowering drug, Bezafibrate, and a contraceptive steroid, Medroxyprogesterone Acetate, could be an effective, non-toxic treatment for a range of cancers, researchers at the University of Birmingham have found.

15 May 2015

Public health advisories reduce rate of codeine dispensed to postpartum women

Public health advisories from the U.S. Food and Drug Administration (FDA) and Health Canada were associated with significant reductions in the rate of dispensing of codeine to postpartum women, according to a study in the May 12 issue of JAMA.

14 May 2015

Small-molecule drug simultaneously rejuvenates old muscles, aging brains

Whether you're brainy, brawny or both, you may someday benefit from a drug found to rejuvenate aging brain and muscle tissue. Researchers at the University of California, Berkeley, have discovered that a small-molecule drug simultaneously perks up old stem cells in the brains and muscles of mice, a finding that could lead to drug interventions for humans that would make aging tissues throughout the body act young again.

14 May 2015

IQWiG examines the added benefit of aclidinium bromide/formoterol drug combination in COPD patients

The fixed-dose combination aclidinium bromide/formoterol has been approved since November 2014 for long-term treatment of adults with chronic obstructive pulmonary disease (COPD).

14 May 2015

Secondhand exposure to cannabis smoke under extreme conditions impairs cognitive performance

Secondhand exposure to cannabis smoke under "extreme conditions," such as an unventilated room or enclosed vehicle, can cause nonsmokers to feel the effects of the drug, have minor problems with memory and coordination, and in some cases test positive for the drug in a urinalysis.

14 May 2015

Patients who report 'weekend-only' drug use expand drug use to weekdays too

More than half of patients who report "weekend-only" drug use end up expanding their drug use to weekdays, too -- suggesting that primary care clinicians should monitor patients who acknowledge "recreational" drug use, says a new study by Boston University public health and medicine researchers.

13 May 2015

FDA licenses Protein Sciences' Pearl River, NY facility to manufacture Flublok influenza vaccine

Protein Sciences Corporation announced that on May 12, 2015 the U.S. Food and Drug Administration licensed its Pearl River, NY manufacturing facility for the commercial manufacturing of Flublok influenza vaccine. Flublok is the world's first licensed influenza vaccine made using modern recombinant technology.

13 May 2015

Unique rheumatoid arthritis diagnostics tool to launch at Hospitalar 2015

An exclusive solution to improve the diagnosis speed of rheumatoid arthritis - one of the world's five most financially burdensome illnesses for the health insurance systems – will be launched by BGE Systems Ltd at Hospitalar 2015...

13 May 2015

Soligenix, Emergent BioSolutions sign development agreement

Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that it has initiated a development agreement with Emergent BioSolutions to implement a commercially viable, scalable production technology for the RiVax drug substance protein antigen.

13 May 2015

DKSH supports Pfizer’s expansion to Laos

DKSH Business Unit Healthcare, the leading partner for healthcare companies seeking to grow their businesses in Asia, has signed an agreement to provide marketing, sales, logistics, distribution, credit management and -collection services to Pfizer in Laos.

12 May 2015

European Investment Bank supports Bavarian Nordic’s development of Ebola and cancer vaccines

The European Investment Bank (EIB), the world’s largest multilateral bank, today reaffirmed its firm commitment to respond to the Ebola pandemic. The Bank has provided a EUR 50 million loan to Bavarian Nordic, an international biopharmaceutical company, for accelerated development of an Ebola vaccine with long-term efficacy. The financing is also backing research into vaccines for treating other infectious diseases and multiple cancer indications.

12 May 2015

CPhI Istanbul 2015 opens as Turkey continues to dominate the MENA pharma region

Turkey is fast emerging as a new hub for pharma manufacturing. This year, CPhI Istanbul will welcome more than 200 exhibitors from 23 Countries and over 4,000 visitors..

12 May 2015

Cardiome signs commercialization agreement with AOP for ESMOCARD products

Cardiome Pharma Corp. today announced that the company has entered a commercialization agreement with AOP Orphan Pharma to sell AOP's cardiovascular products, ESMOCARD and ESMOCARD LYO (esmolol hydrochloride) in Italy, France, Spain and Belgium.

12 May 2015

Study: Disrupting cancer pathway could extend benefits of new immunity-boosting drugs

Understanding how to overrule a signaling pathway that can cause treatments to fail in metastatic melanoma patients should help physicians extend the benefits of recently approved immunity-boosting drugs known as checkpoint inhibitors to more patients.

12 May 2015

Merck KGaA, Darmstadt, Germany granted FDA Fast Track designation for development of evofosfamide

Merck KGaA, Darmstadt, Germany, a leading company for innovative and top-quality high-tech products in healthcare, life science and performance materials today announced that the U.S. Food and Drug Administration has granted Fast Track designation for the development of evofosfamide (previously known as TH-302), administered in combination with gemcitabine, for the treatment of previously untreated patients with metastatic or locally advanced unresectable pancreatic cancer.

12 May 2015

Pharmaceutical News

Linkam and Cambridge IVF work on the development of new protocols for sperm testing

Lab M demonstrates quality with compliance to ISO 11133:2014

Regular use of aspirin may slow the progression of early emphysema, new research shows

Endo Announces Updated XIAFLEX® Label in Patients with Dupuytren’s Contracture

Study compares effectiveness of treatments for metastatic non-clear cell kidney cancers

Combination of contraceptive and cholesterol-lowering drugs kills cancer cells in a new way

Public health advisories reduce rate of codeine dispensed to postpartum women

Small-molecule drug simultaneously rejuvenates old muscles, aging brains

IQWiG examines the added benefit of aclidinium bromide/formoterol drug combination in COPD patients

Secondhand exposure to cannabis smoke under extreme conditions impairs cognitive performance

Patients who report 'weekend-only' drug use expand drug use to weekdays too

FDA licenses Protein Sciences' Pearl River, NY facility to manufacture Flublok influenza vaccine

Unique rheumatoid arthritis diagnostics tool to launch at Hospitalar 2015

Soligenix, Emergent BioSolutions sign development agreement

DKSH supports Pfizer’s expansion to Laos

European Investment Bank supports Bavarian Nordic’s development of Ebola and cancer vaccines

CPhI Istanbul 2015 opens as Turkey continues to dominate the MENA pharma region

Cardiome signs commercialization agreement with AOP for ESMOCARD products

Study: Disrupting cancer pathway could extend benefits of new immunity-boosting drugs

Merck KGaA, Darmstadt, Germany granted FDA Fast Track designation for development of evofosfamide

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Latest News